Biohit Oyj Statistics
Total Valuation
Biohit Oyj has a market cap or net worth of EUR 37.54 million. The enterprise value is 34.34 million.
| Market Cap | 37.54M |
| Enterprise Value | 34.34M |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohit Oyj has 15.20 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | 12.22M |
| Shares Outstanding | 15.20M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 22.92% |
| Owned by Institutions (%) | 0.59% |
| Float | 7.92M |
Valuation Ratios
The trailing PE ratio is 13.89 and the forward PE ratio is 16.47.
| PE Ratio | 13.89 |
| Forward PE | 16.47 |
| PS Ratio | 2.39 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.81, with an EV/FCF ratio of -26.41.
| EV / Earnings | 12.72 |
| EV / Sales | 2.19 |
| EV / EBITDA | 9.81 |
| EV / EBIT | 11.45 |
| EV / FCF | -26.41 |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.53 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | -1.23 |
| Interest Coverage | 30.00 |
Financial Efficiency
Return on equity (ROE) is 19.93% and return on invested capital (ROIC) is 22.92%.
| Return on Equity (ROE) | 19.93% |
| Return on Assets (ROA) | 10.62% |
| Return on Invested Capital (ROIC) | 22.92% |
| Return on Capital Employed (ROCE) | 18.52% |
| Weighted Average Cost of Capital (WACC) | 7.23% |
| Revenue Per Employee | 341,304 |
| Profits Per Employee | 58,696 |
| Employee Count | 46 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 5.36 |
Taxes
In the past 12 months, Biohit Oyj has paid 200,000 in taxes.
| Income Tax | 200,000 |
| Effective Tax Rate | 6.90% |
Stock Price Statistics
The stock price has decreased by -15.59% in the last 52 weeks. The beta is 0.55, so Biohit Oyj's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -15.59% |
| 50-Day Moving Average | 3.29 |
| 200-Day Moving Average | 3.04 |
| Relative Strength Index (RSI) | 20.44 |
| Average Volume (20 Days) | 17,719 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biohit Oyj had revenue of EUR 15.70 million and earned 2.70 million in profits. Earnings per share was 0.18.
| Revenue | 15.70M |
| Gross Profit | 10.80M |
| Operating Income | 3.00M |
| Pretax Income | 2.90M |
| Net Income | 2.70M |
| EBITDA | 3.50M |
| EBIT | 3.00M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 4.80 million in cash and 1.60 million in debt, with a net cash position of 3.20 million or 0.21 per share.
| Cash & Cash Equivalents | 4.80M |
| Total Debt | 1.60M |
| Net Cash | 3.20M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 14.90M |
| Book Value Per Share | 0.98 |
| Working Capital | 5.50M |
Cash Flow
In the last 12 months, operating cash flow was -700,000 and capital expenditures -600,000, giving a free cash flow of -1.30 million.
| Operating Cash Flow | -700,000 |
| Capital Expenditures | -600,000 |
| Free Cash Flow | -1.30M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 68.79%, with operating and profit margins of 19.11% and 17.20%.
| Gross Margin | 68.79% |
| Operating Margin | 19.11% |
| Pretax Margin | 18.47% |
| Profit Margin | 17.20% |
| EBITDA Margin | 22.29% |
| EBIT Margin | 19.11% |
| FCF Margin | n/a |
Dividends & Yields
Biohit Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.18% |
| Shareholder Yield | 0.18% |
| Earnings Yield | 7.19% |
| FCF Yield | -3.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biohit Oyj has an Altman Z-Score of 7.79 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.79 |
| Piotroski F-Score | 3 |